Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Edge Cxbladder Monitor

Pacific Edge has launched the Cxbladder Monitor, a urine-based gene expression test for investigation of bladder cancer in patients being monitored for recurrent disease. The test analyzes urine samples for expression genes, clinical, and patient variable factors that create unique molecular signatures for urothelial carcinoma. It is designed to be used on patients undergoing bladder cancer surveillance to determine if they have a low probability of having recurrence.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more